Immunohistochemistry has been suggested as a way to separate these 2 entities with the tumor cells of EBV+ DLBCL of the elderly typically CD20 positive with variable staining for CD15 and the tumor cells of cHL typically CD15 positive with variable staining for CD20. The gene discussed is FUT4; the disease is diffuse large B-cell lymphoma.